PSTV
USDPLUS THERAPEUTICS Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.500
High
$0.519
Low
$0.491
Volume
5.03M
Company Fundamentals
Market Cap
70.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
20.11M
Exchange
NCM
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Maintains Buy on Plus Therapeutics, Lowers Price Target to $2
HC Wainwright & Co. analyst Sean Lee maintains Plus Therapeutics with a Buy and lowers the price target from $3 to $2.
D. Boral Capital Maintains Buy on Plus Therapeutics, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains Plus Therapeutics with a Buy and maintains $5 price target.
Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights
US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct. 30, 2025 (GLOBE
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch
Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.